|
NDUFA13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.350230E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.596300E-02 |
| Normal-vs-Stage2 |
1.249840E-02 |
| Normal-vs-Stage3 |
4.160300E-02 |
| Normal-vs-Stage4 |
4.881800E-01 |
| Stage1-vs-Stage2 |
1.249030E-01 |
| Stage1-vs-Stage3 |
6.626600E-01 |
| Stage1-vs-Stage4 |
7.848400E-02 |
| Stage2-vs-Stage3 |
2.090600E-01 |
| Stage2-vs-Stage4 |
2.600200E-02 |
| Stage3-vs-Stage4 |
7.376200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.419900E-02 |
| Normal-vs-AfricanAmerican |
1.449960E-01 |
| Normal-vs-Asian |
1.196040E-01 |
| Caucasian-vs-AfricanAmerican |
8.708800E-01 |
| Caucasian-vs-Asian |
9.719600E-01 |
| AfricanAmerican-vs-Asian |
8.729000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.536200E-02 |
| Normal-vs-Female |
1.876020E-02 |
| Male-vs-Female |
8.067200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.222400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.439700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.514300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.369400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.264200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.779400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.323000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.507600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.228000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.701200E-01 |
| Classical-VS-Follicular |
3.69420000000398E-05 |
| Classical-VS-Other |
9.287600E-01 |
| Classical-VS-Normal |
2.740600E-01 |
| Tall-VS-Follicular |
1.501070E-03 |
| Tall-VS-Other |
7.672200E-01 |
| Tall-VS-Normal |
6.994200E-01 |
| Follicular-VS-Other |
2.607900E-02 |
| Follicular-VS-Normal |
2.35610000000053E-05 |
| Other-VS-Normal |
5.655800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.379300E-04 |
| Normal-vs-N1 |
2.287000E-01 |
| N0-vs-N1 |
1.761180E-01 |
|
|
